Showing results (171-180 of 408) with videos related to
Sort By:
Pageof 41
Journal of Infection in Developing Countries|March 13, 2014
Frequency of Pneumocystis jirovecii in sputum from HIV and TB patients in NamibiaVincent Nowaseb, Esegiel Gaeb, Marcin G Fraczek, et al.The Lancet. Infectious Diseases|March 1, 2021
The global incidence and diagnosis of fungal keratitisLottie Brown, Astrid K Leck, Michael Gichangi, et al.FEMS Microbiology Letters|April 19, 2012
Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatusPaul Bowyer, Juan Mosquera, Michael Anderson, et al.The Journal of Antimicrobial Chemotherapy|June 21, 2011
Peripheral neuropathy in patients on long-term triazole antifungal therapyCaroline G Baxter, Andrew Marshall, Mark Roberts, et al.Journal of Medical Case Reports|April 12, 2011
Itraconazole associated quadriparesis and edema: a case reportRangaprasad L Karadi, David Gow, Mark Kellett, et al.Frontiers in Cellular and Infection Microbiology|February 21, 2022
Prospective Evaluation of Positivity Rates of Aspergillus-Specific IgG and Quality of Life in HIV-Negative Tuberculosis Patients in Lagos, NigeriaRita O Oladele, Titi Gbajabimiala, Nicholas Irurhe, et al.Vaccine|November 8, 2015
Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosisChris Kosmidis, Georgina Powell, Ray Borrow, et al.Journal of Fungi (Basel, Switzerland)|March 15, 2018
Burden of Severe Fungal Infections in Burkina FasoSanata Bamba, Adama Zida, Ibrahim Sangaré, et al.Scientific Reports|June 25, 2021
Determining the burden of fungal infections in ZimbabweLorraine T Pfavayi, David W Denning, Stephen Baker, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 3, 2009
Azole-resistance in Aspergillus: proposed nomenclature and breakpointsPaul E Verweij, Susan J Howard, Willem J G Melchers, et al.Pageof 41